AstraZeneca has reportedly held preliminary talks with Bristol Myers Squibb over a potential merger that could create one of the world’s largest pharmaceutical companies, with a combined market value of nearly $400 billion. According to a Reuters source, it remains unclear whether discussions are ongoing. AstraZeneca declined to comment, while Bristol Myers did not
